Delivery Order SPE2DB25D3005-SPE2DB26FQARG
Award Date 10/17/25
Potential Completion Date 10/20/25
Potential Value $5.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,041.42 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with a completion date of July 23, 2025. This non-competitive, firm fixed-price delivery order was issued on July 22, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Repatha is a prescription medication used to treat high cholesterol and reduce the risk of cardiovascular disease. This...
- The Defense Logistics Agency awarded a delivery order valued at $21,846.97 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors on September 22, 2025, with an ultimate completion date of September 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. Repatha (evolocumab) is a PCSK9 inhibitor used to treat high cholesterol and reduce...
- The Defense Logistics Agency awarded a delivery order valued at $1,802.00 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and specifies performance at the awardee's corporate office location in Conshohocken, Pennsylvania. Repatha is a prescription medication used to lower cholesterol levels in patients with...
- The Defense Logistics Agency awarded a delivery order valued at $2,542.31 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of September 24, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded on September 23, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. Repatha is a PCSK9 inhibitor used to treat high cholesterol in patients at risk for cardiovascular...
- The Defense Logistics Agency's Medical Supply Chain awarded a $41,519.06 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. This firm fixed-price, non-set-aside contract is expected to be completed by September 22, 2025, with performance taking place at the awardee's corporate office location in Conshohocken, Pennsylvania. Repatha is a PCSK9 inhibitor used to reduce LDL cholesterol levels and is essential for...
- The Defense Logistics Agency awarded a $34,401.14 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector medication, with an ultimate completion date of September 9, 2025. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation. The award was issued on September 8, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Repatha is a prescription medication...
- The Defense Logistics Agency awarded a delivery order valued at $1,962.21 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Repatha is a prescription medication used to lower cholesterol levels, and this delivery...
- The Defense Logistics Agency awarded a delivery order valued at $5,390.03 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. This competitive award, issued on June 2, 2025, with an ultimate completion date of June 3, 2025, represents a firm fixed-price transaction with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Repatha is a PCSK9 inhibitor used to treat high cholesterol and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors, valued at $18,082.21. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award practices. The contract is set to be completed by September 10, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Repatha is a PCSK9 inhibitor used...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors valued at $7,567.40 on August 26, 2025, with an ultimate completion date of August 27, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a prime vendor for federal pharmaceutical procurement and will fulfill this order from its...